Upstream Bio (UPB) Current Assets: 2023-2025
Historic Current Assets for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $389.0 million.
- Upstream Bio's Current Assets rose 71.17% to $389.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $389.0 million, marking a year-over-year increase of 71.17%. This contributed to the annual value of $479.2 million for FY2024, which is 309.55% up from last year.
- Latest data reveals that Upstream Bio reported Current Assets of $389.0 million as of Q3 2025, which was down 6.99% from $418.3 million recorded in Q2 2025.
- Upstream Bio's 5-year Current Assets high stood at $479.2 million for Q4 2024, and its period low was $117.0 million during Q4 2023.
- For the 3-year period, Upstream Bio's Current Assets averaged around $347.4 million, with its median value being $403.6 million (2025).
- Data for Upstream Bio's Current Assets shows a peak YoY surged of 309.55% (in 2024) over the last 5 years.
- Quarterly analysis of 3 years shows Upstream Bio's Current Assets stood at $117.0 million in 2023, then surged by 309.55% to $479.2 million in 2024, then spiked by 71.17% to $389.0 million in 2025.
- Its Current Assets was $389.0 million in Q3 2025, compared to $418.3 million in Q2 2025 and $453.8 million in Q1 2025.